Skip to main content
Lytix Biopharma ASA (OSL:LYTIX)
Norway flag Norway · Delayed Price · Currency is NOK
9.58
-0.22 (-2.24%)
Nov 13, 2026, 4:25 PM CET

Lytix Biopharma ASA Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
737674401195311533
Market Cap Growth
-2.77%68.03%106.12%-37.37%-41.63%-
Enterprise Value
671587361116139323
Last Close Price
9.589.835.854.847.7213.69

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--36.0548.7928.1927.59
PB Ratio
11.5710.923.723.802.302.81
P/TBV Ratio
11.5710.923.723.802.302.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--32.3929.0612.6316.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.040.020.010.010.01
Net Debt / Equity Ratio
-1.03-1.14-1.19-0.97-1.06-1.03
Net Debt / EBITDA Ratio
0.641.101.340.522.194.11
Net Debt / FCF Ratio
0.651.171.820.522.734.37
Asset Turnover
--0.110.040.060.16
Quick Ratio
6.364.233.905.018.5114.29
Current Ratio
6.364.283.915.068.5514.33
Return on Equity (ROE)
-137.04%-70.71%-118.41%-94.33%-34.54%-45.90%
Return on Assets (ROA)
-74.91%-35.09%-56.97%-55.72%-22.90%-25.23%
Return on Capital Employed (ROCE)
-160.10%-101.70%-87.40%-188.40%-48.50%-25.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.22%-8.89%-23.48%-45.14%-18.03%-9.03%
FCF Yield
-13.68%-8.87%-17.53%-49.31%-16.98%-8.37%
Buyback Yield / Dilution
--26.05%-35.05%-1.01%-19.50%-26.57%